Nature Communications (May 2024)

Acinar to β-like cell conversion through inhibition of focal adhesion kinase

  • Shakti Dahiya,
  • Mohamed Saleh,
  • Uylissa A. Rodriguez,
  • Dhivyaa Rajasundaram,
  • Jorge R. Arbujas,
  • Arian Hajihassani,
  • Kaiyuan Yang,
  • Anuradha Sehrawat,
  • Ranjeet Kalsi,
  • Shiho Yoshida,
  • Krishna Prasadan,
  • Heiko Lickert,
  • Jing Hu,
  • Jon D. Piganelli,
  • George K. Gittes,
  • Farzad Esni

DOI
https://doi.org/10.1038/s41467-024-47972-4
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Insufficient functional β-cell mass causes diabetes; however, an effective cell replacement therapy for curing diabetes is currently not available. Reprogramming of acinar cells toward functional insulin-producing cells would offer an abundant and autologous source of insulin-producing cells. Our lineage tracing studies along with transcriptomic characterization demonstrate that treatment of adult mice with a small molecule that specifically inhibits kinase activity of focal adhesion kinase results in trans-differentiation of a subset of peri-islet acinar cells into insulin producing β-like cells. The acinar-derived insulin-producing cells infiltrate the pre-existing endocrine islets, partially restore β-cell mass, and significantly improve glucose homeostasis in diabetic mice. These findings provide evidence that inhibition of the kinase activity of focal adhesion kinase can convert acinar cells into insulin-producing cells and could offer a promising strategy for treating diabetes.